Schroder Investment Management Group / TMO
Schroder Investment Management Group’s Thermo Fisher Scientific Inc Position
Does Schroder Investment Management Group own Thermo Fisher Scientific Inc (TMO)? Yes — 1.73M shares worth $850M (+0.70% of its 13F portfolio) as of Q1 2026, down from 1.74M shares the prior filed quarter.
Position Value
$850M
Q1 2026
Shares
1.73M
% of Portfolio
+0.70%
Quarters Held
30
currently held
Position History TMO
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 1.73M | $850M | +0.70% |
| Q4 2025 | 1.74M | $1.0B | +0.76% |
| Q3 2025 | 1.73M | $837M | +0.65% |
| Q2 2025 | 1.61M | $654M | +0.55% |
| Q1 2025 | 1.64M | $818M | +0.83% |
| Q4 2024 | 1.68M | $873M | +0.84% |
| Q3 2024 | 1.61M | $995M | +1.02% |
| Q2 2024 | 1.59M | $881M | +0.97% |
| Q1 2024 | 1.48M | $857M | +1.01% |
| Q4 2023 | 1.31M | $693M | +0.90% |
| Q3 2023 | 1.14M | $579M | +0.86% |
| Q2 2023 | 1.09M | $571M | +0.82% |
| Q1 2023 | 1.09M | $629M | +0.94% |
| Q4 2022 | 1.15M | $636M | +1.01% |
| Q3 2022 | 1.17M | $595M | +0.98% |
| Q2 2022 | 1.13M | $613M | +0.93% |
| Q1 2022 | 1.06M | $626M | +0.83% |
| Q4 2021 | 1.00M | $668M | +0.87% |
| Q3 2021 | 874.7K | $500M | +0.77% |
| Q2 2021 | 871.7K | $440M | +0.55% |
| Q1 2021 | 825.1K | $377M | +0.49% |
| Q4 2020 | 2.10M | $978M | +0.69% |
| Q3 2020 | 1.04M | $453M | +0.72% |
| Q2 2020 | 867.7K | $314M | +0.57% |
| Q1 2020 | 873.7K | $266M | +0.57% |
| Q4 2019 | 857.0K | $278M | +0.45% |
| Q3 2019 | 1.14M | $327M | +0.58% |
| Q2 2019 | 982.2K | $288M | +0.52% |
| Q1 2019 | 956.6K | $262M | +0.47% |
| Q4 2018 | 997.9K | $223M | +0.40% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Schroder Investment Management Group’s full portfolio or all institutional holders of TMO.